Drug Development Global Program

A quarterly e-newsletter about our work in drug development

A Healthy Dose provides quarterly updates on our efforts to ensure that safe and effective medicines are available and accessible to all those who need them. The e-newsletter contains news about our research, product development milestones, partnerships, and other activities and related resources.

Sign up for A Healthy Dose.

Click on the links below to access past issues on the Campaign Monitor website.

January 2017

  • New partnership to expand PATH’s work in soil-transmitted helminths
  • Explore new content on our subsite
  • Oxygen is a matter of life and breath
  • DefeatDD poo haiku campaign
  • Focused pharmacovigilance for kala-azar in Bangladesh and Nepal
  • Post-kala-azar dermal leishmaniasis/visceral leishmaniasis relapse study in Bangladesh
  • Presentations on diarrhea and pneumonia
  • Diarrhea Innovations Group at ASTMH Annual Meeting

October 2016

  • PATH receives prestigious Tech Award
  • Breaking the cycle of soil-transmitted helminth infections
  • DefeatDD: Superheroes vs. Villains video
  • Connecting with innovators at JLABS
  • Diarrhea Innovations Group at ASTMH

June 2016

  • A novel route to malaria treatments: semisynthetic artemisinin
  • Pharmacovigilance for kala-azar in Nepal
  • New factsheet: Oxygen therapy for newborn and child health
  • New DefeatDD video: The Financial, Physical, and Emotional Toll of Chronic Diarrhea
  • Diarrhea Innovations Group annual meeting
  • Bay Area global health happenings
  • GHTC briefing
  • A vicious cycle: diarrhea and malnutrition

March 2016

  • PATH hosts symposium on Cryptosporidium
  • Grant from GHIT Fund for intestinal worms drug research
  • ACCORD to save lives
  • Coast to coast science
  • Why is malnutrition so hard to treat?

December 2015

  • New Diarrhea Innovations Group launches
  • World Toilet Day 2015 and #TravelingPoo
  • The Pneumonia Innovations Summit
  • At the ASTMH annual meeting
  • Brainstorming with Bay Area innovators
  • Engaging on nutrition in Seattle
  • PATH in San Francisco

September 2015

  • 23 countries receive antimalarials made with semisynthetic artemisinin
  • Clinical update
  • Crypto, the new old threat
  • PATH’s Bay Area office moves to San Francisco
  • On the move
  • Innovation Countdown 2030 report

June 2015

  • World Malaria Day 2015
  • Enrollment underway for HIV PrEP phase 2 trial
  • Improving treatments in pneumonia
  • Millions of malaria drugs made with ssART shipped
  • #DefeatMalaria campaign
  • #Blue4Water on World Water Day
  • When I think of drug development…

March 2015

  • New safety trial for injectable PrEP to prevent HIV
  • Call for better HIV prevention technologies for women and girls
  • Novel drug safety model for visceral leishmaniasis patients
  • PKDL Consortium advocates unified approach
  • CROI 2015
  • Investigational new drug—make it or break it

December 2014

  • Dr. David Shoultz to lead drug development at PATH
  • Clinical update: HIV PrEP
  • Commemorating Global Handwashing Day and World Toilet Day
  • International Artemisinin Conference
  • HIV Research for Prevention
  • GAPPD: Why tackle diarrhea and pneumonia together?

August 2014

  • First batches of ACTs made with semisynthetic artemisinin are on the way to reaching patients
  • New video: Defeat diarrheal disease? Together, we’ve got it covered.
  • Grant enables PATH to expand search for drugs against diarrhea
  • Voices from our team and partners
  • #StepUp4Women Twitter chat
  • South San Francisco summer BBQ
  • Ending preventable child and maternal deaths
  • What does “cross-sector partnership” really mean?

May 2014

  • Thanks for joining #DefeatMalaria!
  • The #DefeatMalaria blog series
  • New resources!
  • World Malaria Day 2014
  • HIV/AIDS conferences
  • Speaking to the American Medical Writer’s Association
  • Digestive Disease Week
  • Why semisynthetic?

February 2014

  • Hemingway-inspired drug development
  • Antisecretory drug candidate advances
  • New ORS formulations identified
  • Innovation. Transformation. Inspiration.
  • CEND Annual Symposium
  • Capitol Hill briefing at ASTMH
  • Conference tackles intellectual property
  • What are the shortcomings of ORS for diarrheal disease treatment?
  • Submissions to PATH’s Drug Development program blog

November 2013

  • Advancing HIV prevention through partnerships
  • DfID invests in PATH partnership to address deadly diseases
  • Rep. Jacqueline Speier visits PATH office
  • Elimination and eradication of malaria the focus at MIM
  • Dr. Eugenio de Hostos at Stanford
  • SOCAP13 in San Francisco
  • Workshop focuses on drug safety
  • Examining revised guidelines for kala-azar in Nepal
  • Failing early: why it’s a good thing
  • We want to hear from you!

July 2013

  • WHO prequalifies ssART
  • Development of iOWH032 continues
  • Expanding research to treat deadly diarrhea
  • Launching commercial production of ssART
  • Advancing oral rehydration solution
  • Protecting kids from worms in India
  • Semisynthetic artemisinin launch
  • Child health congressional briefing
  • World Malaria Day
  • Dr. Robert Choy at UCSF
  • #LetsTalkDiarrhea contest winner
  • What is semisynthetic artemisinin?

April 2013

  • From the lab to the factory floor
  • Key malaria drug derivative reaches industrial scale
  • Antisecretory drug candidate to enter next clinical phase
  • Strengthening local clinical research in India
  • Discovery program gets boost from Novartis
  • Artemisinin Conference 2013
  • PDP Access Group
  • #LetsTalkDiarrhea contest
  • Renewing US leadership in global health
  • Dr. Eugenio de Hostos speaks at Santa Clara
  • A closer look at iOWH032